Survival Benefit of Combination Chemotherapy in Elderly Patients with Metastatic Pancreatic Ductal Adenocarcinoma

OBJECTIVES: Survival benefit of combination over single-agent chemotherapy for metastatic pancreatic ductal adenocarcinoma (PDAC) was demonstrated in younger patients in clinical trials. We aimed to evaluate whether this survival benefit of combination chemotherapy is present in elderly patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Oncol
Main Authors: Xie, Hao, Liu, Junjia, Ogden, John R., Yin, Jun, Jatoi, Aminah, Hubbard, Joleen M., McWilliams, Robert R., Mahipal, Amit, Petersen, Gloria M., Bekaii-Saab, Tanios S., Ma, Wen Wee
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7395872/
https://ncbi.nlm.nih.gov/pubmed/32349022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000708
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados